MANE
Veradermics, Incorporated · Healthcare · Biotechnology
动量输入(同类管理人):
持有人广度 +30.0% ·
股份流向 +30.0% ·
净新建仓位 +20.0%
· 公式
广泛增持:持股数量上升,持有人数量增加
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q1 2026
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 1.83M | 新增 | $115.29M | 0.1% | New | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 1.79M | 新增 | $113.22M | 0.0% | New | 1 | SEC ↗ ×4 |
| 3 | Viking Global Investors ✦ | 1.69M | 新增 | $106.76M | 0.3% | New | 1 | SEC ↗ |
| 4 | Adage Capital Partners ✦ | 1.10M | 新增 | $69.47M | 0.1% | New | 1 | SEC ↗ |
| 5 | Aberdeen Group plc | 1.05M | 新增 | $66.60M | 0.1% | New | 1 | SEC ↗ |
| 6 | JPMorgan Chase ✦ | 976.17K | 新增 | $59.40M | 0.0% | New | 1 | SEC ↗ ×4 |
| 7 | Vanguard Capital Management Llc | 699.64K | n/a | $44.18M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 654.60K | 新增 | $41.34M | 0.0% | New | 1 | SEC ↗ ×3 |
| 9 | Balyasny Asset Management L.P. | 532.91K | 新增 | $33.65M | 0.1% | New | 1 | SEC ↗ |
| 10 | Ameriprise Financial Inc | 514.03K | 新增 | $32.46M | 0.0% | New | 1 | SEC ↗ ×2 |
| 11 | Wellington Management ✦ | 477.83K | 新增 | $30.18M | 0.0% | New | 1 | SEC ↗ ×5 |
| 12 | UBS Group AG | 347.07K | 新增 | $21.92M | 0.0% | New | 1 | SEC ↗ ×2 |
| 13 | Stifel Financial Corp | 294.12K | 新增 | $18.57M | 0.0% | New | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 282.61K | 新增 | $17.85M | 0.0% | New | 1 | SEC ↗ ×3 |
| 15 | Franklin Resources Inc | 200.00K | 新增 | $12.63M | 0.0% | New | 1 | SEC ↗ |
| 16 | Geode Capital Management ✦ (被动) | 178.21K | 新增 | $11.26M | 0.0% | New | 1 | SEC ↗ ×2 |
| 17 | Goldman Sachs Group ✦ | 168.97K | 新增 | $10.67M | 0.0% | New | 1 | SEC ↗ |
| 18 | Ensign Peak Advisors, Inc | 150.00K | 新增 | $9.47M | 0.0% | New | 1 | SEC ↗ |
| 19 | Jennison Associates Llc | 141.78K | 新增 | $8.95M | 0.0% | New | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 134.22K | 新增 | $8.48M | 0.0% | New | 1 | SEC ↗ |
| 21 | Millennium Management ✦ | 123.22K | 新增 | $7.78M | 0.0% | New | 1 | SEC ↗ |
| 22 | Charles Schwab Investment… | 98.01K | 新增 | $6.19M | 0.0% | New | 1 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (被动) | 74.40K | 新增 | $4.70M | 0.0% | New | 1 | SEC ↗ |
| 24 | Bank Of America Corp /De/ | 65.67K | 新增 | $4.15M | 0.0% | New | 1 | SEC ↗ |
| 25 | Bamco Inc /Ny/ | 59.67K | 新增 | $3.77M | 0.0% | New | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 51.69K | 新增 | $3.26M | 0.0% | New | 1 | SEC ↗ ×4 |
| 27 | Barclays Plc | 36.91K | 新增 | $2.33M | 0.0% | New | 1 | SEC ↗ ×3 |
| 28 | Northern Trust Corp | 34.54K | 新增 | $2.18M | 0.0% | New | 1 | SEC ↗ |
| 29 | First Trust Advisors Lp | 19.77K | 新增 | $1.25M | 0.0% | New | 1 | SEC ↗ |
| 30 | Squarepoint Ops LLC | 16.61K | 新增 | $1.05M | 0.0% | New | 1 | SEC ↗ |
| 31 | Toronto Dominion Bank | 13.43K | 新增 | $847,978 | 0.0% | New | 1 | SEC ↗ |
| 32 | CIBC Bancorp USA Inc. | 13.10K | n/a | $827,265 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Citigroup Inc | 10.69K | 新增 | $675,137 | 0.0% | New | 1 | SEC ↗ |
| 34 | Legal & General Group Plc | 7.11K | 新增 | $448,681 | 0.0% | New | 1 | SEC ↗ |
| 35 | Bank of New York Mellon Corp | 3.67K | 新增 | $231,634 | 0.0% | New | 1 | SEC ↗ |
| 36 | Us Bancorp \De\ | 470 | 新增 | $29,681 | 0.0% | New | 1 | SEC ↗ |
| 37 | Royal Bank Of Canada | 8 | 新增 | $1,000 | 0.0% | New | 1 | SEC ↗ |
| 38 | Jones Financial Companies Lllp | 10 | 新增 | $655 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $115.29M | 0.1% |
| Fidelity (FMR) | $113.22M | 0.0% |
| Viking Global Investors | $106.76M | 0.3% |
| Adage Capital Partners | $69.47M | 0.1% |
| Aberdeen Group plc | $66.60M | 0.1% |
| JPMorgan Chase | $59.40M | 0.0% |
| Marshall Wace | $41.34M | 0.0% |
| Balyasny Asset Management L.P. | $33.65M | 0.1% |
| Ameriprise Financial Inc | $32.46M | 0.0% |
| Wellington Management | $30.18M | 0.0% |
| UBS Group AG | $21.92M | 0.0% |
| Stifel Financial Corp | $18.57M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 79 持有人, 24.94M 股份, $1.57B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Director · 690.60K 股 · $74.07M
Director · 59.40K 股 · $6.37M
Officer · 16.31K 股 · $1.75M
Officer · 16.77K 股 · $1.82M
Officer · 2.35K 股 · $256,730
Officer · 161 股 · $17,916
Officer · 7.92K 股 · $844,930
Director · 80.00K 股 · $8.58M
Director · 5.00K 股 · $541,200
Director · 15.00K 股 · $1.59M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
8.8% 占股份类别 · 查看 SEC 原始申报文件 ↗
4.9% 占股份类别 · 查看 SEC 原始申报文件 ↗